关于CAR T细胞治疗的非正规性和死亡率决定性毒性
Kai Rejeski1,2,3, Joshua A Hill4,5, Saurabh Dahiya6
1Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany. kai.rejeski@med.uni-muenchen.de.
Nature medicine
|July 16, 2025
概括
化学抗原受体 (CAR) T细胞疗法除了细胞因子释放综合征 (CRS) 和神经毒性 (ICANS) 之外,还具有独特的毒性. 了解罕见和严重的副作用对于改善患者管理和治疗结果至关重要.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 卡尔-T细胞疗法具有独特的毒性,影响患者的发病率和生活质量.
- 已建立的细胞因子释放综合征 (CRS) 和免疫效应细胞相关神经毒性综合征 (ICANS) 的分级系统改善了急性毒性管理.
- 不断发展的CAR T细胞应用需要对新出现的和罕见的毒性有更深入的了解.
研究的目的:
- 审查目前关于CAR T细胞疗法的死亡率决定性和罕见毒性知识,超越CRS和ICANS.
- 阐明这些新型毒性背后的机制,包括目标损伤和细胞因子相关的炎症.
- 确定未满足的需求,并提出未来的研究重点,以实现标准化报告和改善临床管理.
主要方法:
- 关于CAR T细胞治疗毒性的文献综述.
- 分析机制,包括目标损伤,细胞因子相关的炎症和失调的恢复.
- 综合当前关于罕见和严重不良事件的知识.
主要成果:
- 卡尔-T细胞疗法与CRS和ICANS之外的一系列毒性有关.
- 诸如目标损伤,细胞因子相关炎症和失调的恢复等机制有助于毒性.
- 了解这些机制有助于预测毒性时间和指导管理策略.
结论:
- 对于罕见和严重的CAR T细胞毒性,有必要理解和标准化报告.
- 阐明潜在机制是改善临床管理和患者结果的关键.
- 未来的研究应该专注于解决毒性评估和管理方面的未满足需求.
相关概念视频
01:27Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
01:27Cytotoxic T Cells-mediated Immune Response
2.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.3K
01:25Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K